NASDAQ · PMCB

PharmaCyte Biotech, Inc.

Closing price · Nov 13, 2026 $6.68
Last insider buy price $0.83 Paid by CEO and President, Director Joshua Silverman on Jan 7, 2026 (Form 4). Not today's price.

Latest quarter · ended Jul 31, 2026

Sales slipped and cash got weaker

descriptionFiled Sep 14, 2026
Revenue growth
—Sales for the quarter: $0
Cash from operationsBetter
−$781K
Quarter ended Oct 31, 2024: −$1.05M cash from operationsQuarter ended Jan 31, 2025: −$510K cash from operationsQuarter ended Apr 30, 2025: −$1.04M cash from operationsQuarter ended Jul 31, 2025: −$1.99M cash from operationsQuarter ended Oct 31, 2025: −$980K cash from operationsQuarter ended Jan 31, 2026: −$787K cash from operationsQuarter ended Apr 30, 2026: −$1.39M cash from operationsQuarter ended Jul 31, 2026: −$781K cash from operations
Oct '24Jul '26
vs. −$1.99M a year ago
Share countDiluting
+58.0%
Quarter ended Oct 31, 2024: 6.97M sharesQuarter ended Jan 31, 2025: 6.86M sharesQuarter ended Apr 30, 2025: 6.8M sharesQuarter ended Jul 31, 2025: 6.8M sharesQuarter ended Oct 31, 2025: 10.13M sharesQuarter ended Jan 31, 2026: 10.74M sharesQuarter ended Apr 30, 2026: 10.74M sharesQuarter ended Jul 31, 2026: 10.74M shares
Oct '24Jul '26
10.74M shares vs. 6.8M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

29 funds report owning PMCB, down from 32

Holdings as of Jun 30, 2026
New4
Added5
Held12
Trimmed8
Sold out7

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Dec 12 · 300,000 sh · 4 peopleShares withheld for tax · Dec 12 · $138K · 4 peopleStock grant · Dec 12 · 575,000 shShares withheld for tax · Dec 12 · $264KOpen-market buy · Jan 5 · $15.6KOpen-market buy · Jan 5 · $23.4KOpen-market buy · Jan 6 · $15.8KOpen-market buy · Jan 6 · $23.7KOpen-market buy · Jan 7 · $16.8KOpen-market buy · Jan 7 · $33.2K
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Dec 12 · 300,000 sh · 4 peopleShares withheld for tax · Dec 12 · $138K · 4 peopleStock grant · Dec 12 · 575,000 shShares withheld for tax · Dec 12 · $264KOpen-market buy · Jan 5 · $15.6KOpen-market buy · Jan 5 · $23.4KOpen-market buy · Jan 6 · $15.8KOpen-market buy · Jan 6 · $23.7KOpen-market buy · Jan 7 · $16.8KOpen-market buy · Jan 7 · $33.2K

Last 12 months. No real trades in the last 6.

Showing 6 real trades. Hidden: 5 stock grants, 5 tax withholdings. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Jan 7 Joshua Silverman CEO and President, Director Open-market buy $33.2K 40,000 sh at $0.83
Jan 7 Jonathan Schechter Director Open-market buy $16.8K 20,000 sh at $0.84
Jan 6 Joshua Silverman CEO and President, Director Open-market buy $23.7K 30,000 sh at $0.79
Jan 6 Jonathan Schechter Director Open-market buy $15.8K 20,000 sh at $0.79
Jan 5 Joshua Silverman CEO and President, Director Open-market buy $23.4K 30,000 sh at $0.78
Jan 5 Jonathan Schechter Director Open-market buy $15.6K 20,000 sh at $0.78

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in PMCB

As of Jun 30, 2026
FundOwnsValueChange
Citadel Advisors LLC2.6%$218K−21%
Geode Capital Management, LLC1.2%$95.7K−36%
Vanguard Capital Management LLC0.5%$43.7K+10%
Susquehanna International Group, LLP0.4%$34.5KNew
Renaissance Technologies LLC0.4%$29.2K−33%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast